298 results on '"Vitale, Mario"'
Search Results
2. Sustainable transformation in the Latin American and Caribbean districts through the implementation of a qualitative methodology. Challenges and key aspects to be addressed
3. Application of validated bleeding risk scores for atrial fibrillation in obscure gastrointestinal bleeding patients increases videocapsule endoscopy’s diagnostic yield: a retrospective monocentric study
4. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis
5. Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life.
6. Resilient companies in the time of Covid-19 pandemic: a case study approach
7. The Essential Characteristics of a Great Managing General Agent: Carriers must ensure that their MGA partners are well managed, reliable and financially strong. Perhaps most importantly, carriers must have confidence in the honesty and integrity of an MGA's owners and managers
8. The role of a multidisciplinary approach in the choice of the best surgery approach in a super-super-obesity case
9. Detection of RAS mutation by pyrosequencing in thyroid cytology samples
10. Antiglioma effects of N6‐isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor
11. Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication
12. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy
13. BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay
14. Benign thyroid nodules with RAS mutation grow faster
15. Radioiodide induces apoptosis in human thyroid tissue in culture
16. Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives
17. Hypocalcaemia after total thyroidectomy: Could intact parathyroid hormone be a predictive factor for transient postoperative hypocalcemia?
18. Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management.
19. BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma
20. Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells
21. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice
22. Thyroid dysfunction following a kelp-containing marketed diet
23. Fine-needle cytology of Hürthle cell tumors and morphometry
24. Retraction notice to “PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines” [Eur. J. Pharmacol. 714(1–3) (2013) 379–387]
25. Unexpected prevalence of hyperprolactinaemia associated with microprolactinoma and empty sella in a cohort of adult patients with non-transfusion-dependent thalassaemia: a prospective study
26. Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state
27. BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimotoʼs thyroiditis lymphocytic infiltration is present
28. PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines
29. Mutational testing and its utility in thyroid cancer management: the need for something more
30. SEREX: a promising approach for identification of thyroid cancer serological biomarkers
31. Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
32. Preoperative colonoscopy after self-expandable metallic stent placement in patients with acute neoplastic colon obstruction
33. Routine ileoscopy at colonoscopy: a prospective evaluation of learning curve and skill-keeping line
34. A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome
35. The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma
36. High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements
37. Targeted Therapy for Thyroid Cancer: Striking the Survival Signaling
38. Differential Activation of Signaling Pathways Involved in Cell Death, Survival and Inflammation by Radiocontrast Media in Human Renal Proximal Tubular Cells
39. Thyroid adiponcosis: more than an hypothesis
40. Dry-compressing vacuum pumps increase productivity and reduce operating costs in demanding heat-treatment applications
41. Lovastatin Enhances the Replication of the Oncolytic Adenovirus dl1520 and Its Antineoplastic Activity against Anaplastic Thyroid Carcinoma Cells
42. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings
43. Aurora B Expression Directly Correlates With Prostate Cancer Malignancy and Influence Prostate Cell Proliferation
44. Anandamide inhibits adhesion and migration of breast cancer cells
45. Fibronectin-Induced Proliferation in Thyroid Cells Is Mediated by αvβ3 Integrin through Ras/Raf-1/MEK/ERK and Calcium/CaMKII Signals
46. The Different Cardiac Expression of the Type 2 Iodothyronine Deiodinase Gene between Human and Rat Is Related to the Differential Response of the dio2 Genes to Nkx-2.5 and GATA-4 Transcription Factors
47. Analysis of Cancer/Testis Antigens in Sporadic Medullary Thyroid Carcinoma: Expression and Humoral Response to NY-ESO-1
48. Integrin-Dependent Cell Growth and Survival Are Mediated by Different Signals in Thyroid Cells
49. Amiodarone Induces Cytochrome c Release and Apoptosis through an Iodine-Independent Mechanism*
50. Serum Withdrawal-Induced Apoptosis in Thyroid Cells Is Caused by Loss of Fibronectin-Integrin Interaction*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.